A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in later stages of the disease.
Category: DNA (Deoxyribonucleic Acid)
-
A Cancer Detection Test Fails in Major Study
The New York Times – Business: -
23andMe Customers Did Not Expect Their DNA Data Would Be Sold, Lawsuit Claims
The genetic-testing company, which collected DNA data from users, is for sale in bankruptcy court. Now, 27 states and the District of Columbia oppose selling the data without express consent.
-
23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million
Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.
-
As 23andMe Struggles, Concerns Surface About Its Genetic Data
A plummet in the company’s valuation and a recent board resignation have raised questions about the future of genetic data collected from millions of customers.
-
How AI and DNA Are Unlocking the Mysteries of Global Supply Chains
Firms are turning to advanced technologies to help answer a surprisingly tricky question: Where do products really come from?
-
DNA From Beethoven’s Hair Unlocks Medical and Family Secrets
The New York Times – Music:By analyzing seven samples of hair said to have come from Ludwig van Beethoven, researchers debunked myths about the revered composer while raising new questions about his life and death.